STACEY BARNETT: Open Payments
NPI 1194238790 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 8 payments from 4 companies in 2025. Trend: 2023 $169 · 2024 $152 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: Veklury, XIFAXAN, Ozempic, VRAYLAR.
Industry payments across AL — which companies pay providers there.
